WeLeader Biomedical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	232.13	237.71	174.97	94.69	100.73	111.52
Short-Term Investments	75.18	97	34.37	7.83	8.4	4.18
Trading Asset Securities	50.06	-	2.83	2.43	2.33	3.01
Cash & Short-Term Investments	357.36	334.71	212.17	104.95	111.45	118.71
Cash Growth	-3.63%	57.76%	102.16%	-5.83%	-6.11%	-
Accounts Receivable	310.11	322.51	276.87	273.63	279.43	290.68
Other Receivables	-	-	-	0.05	0.1	1.03
Receivables	310.11	322.51	276.87	273.69	279.52	291.71
Inventory	133.07	117.93	99.06	69.67	62.73	55.89
Other Current Assets	6.25	5.23	3.21	2.11	1.02	2.11
Total Current Assets	806.79	780.39	591.32	450.42	454.73	468.42
Property, Plant & Equipment	1,590	1,589	1,341	1,194	1,086	351.66
Long-Term Investments	42.54	43.13	26.82	42.87	27.84	29.6
Other Intangible Assets	2.7	2.47	4.06	3.88	5.74	6.13
Long-Term Deferred Tax Assets	0.77	0.67	0.46	0.69	0.79	0.49
Other Long-Term Assets	33.22	33.5	34.63	36.02	25.24	26.8
Total Assets	2,476	2,449	1,998	1,728	1,600	883.09
Accounts Payable	199.1	214.45	183.54	143.19	155.28	160.65
Accrued Expenses	49.62	68.9	56.82	55.27	48.18	44.01
Short-Term Debt	-	-	80	57	121.03	53
Current Portion of Long-Term Debt	1.03	1.03	17.44	16.97	15.02	13.63
Current Portion of Leases	90.89	95.52	81.43	74.62	49.75	53.93
Current Income Taxes Payable	45.09	31.06	25.54	23.87	34.46	23.84
Current Unearned Revenue	5.14	5.2	1.52	0.34	0.7	1.95
Other Current Liabilities	200.39	16.15	22.71	30.43	14.13	12.81
Total Current Liabilities	591.26	432.3	469.01	401.69	438.54	363.81
Long-Term Debt	490.98	488.43	397.96	249.03	270.23	18.65
Long-Term Leases	267.49	268.14	219.94	228.38	245.22	142.99
Long-Term Deferred Tax Liabilities	0.01	-	-	-	-	0
Other Long-Term Liabilities	-	-	2.69	2.69	0.2	0.22
Total Liabilities	1,350	1,189	1,090	881.78	954.19	525.68
Common Stock	454.79	454.79	415.79	415.79	342.46	193.49
Additional Paid-In Capital	384.31	384.31	141.13	141.13	92.96	8.73
Retained Earnings	273.07	406.54	351.16	276.57	213.89	155.2
Comprehensive Income & Other	14.49	14.49	0.39	12.29	-3.01	-
Shareholders' Equity	1,127	1,260	908.47	845.78	646.3	357.41
Total Liabilities & Equity	2,476	2,449	1,998	1,728	1,600	883.09
Total Debt	850.38	853.11	796.77	626	701.25	282.19
Net Cash (Debt)	-493.02	-518.4	-584.6	-521.05	-589.79	-163.49
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-10.12	-11.16	-14.01	-12.68	-19.38	-5.82
Filing Date Shares Outstanding	45.48	45.48	41.58	41.59	34.25	27.88
Total Common Shares Outstanding	45.48	45.48	41.58	41.59	34.25	27.88
Working Capital	215.53	348.08	122.31	48.73	16.19	104.61
Book Value Per Share	24.77	27.71	21.85	20.34	18.87	12.82
Tangible Book Value	1,124	1,258	904.41	841.9	640.56	351.28
Tangible Book Value Per Share	24.71	27.65	21.75	20.24	18.70	12.60
Land	652.61	652.61	652.61	652.61	657.23	4.62
Buildings	-	-	-	-	11.93	11.93
Machinery	18.29	20.01	19.46	28.53	25.97	24.65
Construction In Progress	531.7	519.58	318.14	144.95	7.43	0.38